loading

Finanzdaten der Mineralys Therapeutics Inc-Aktie (MLYS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
27.61%
35.36
27.71 26.27 15.73 14.94
Operating Income/Loss
27.61%
-35.36
-27.71 -26.27 -15.73 -14.94
Nonoperating Income/Loss
16.01%
3.854
3.322 3.513 3.594 2.33
Income/Loss From Continuing Operations Before Tax
29.19%
-31.51
-24.39 -22.76 -12.14 -12.61
Income/Loss From Continuing Operations After Tax
29.19%
-31.51
-24.39 -22.76 -12.14 -12.61
Net Income/Loss
29.19%
-31.51
-24.39 -22.76 -12.14 -12.61
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,312%
44.90
1.316 39.93 39.75 24.76
Diluted Average Shares
3,312%
44.90
1.316 39.93 39.75 24.76
Basic Earnings Per Share
11.11%
-0.70
-0.63 -0.57 -0.31 -0.51
Diluted Earnings Per Share
11.11%
-0.70
-0.63 -0.57 -0.31 -0.51
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):